BioSpace News Archive

Company to present on Tuesday, November 16th, 2021 at 6:20 am PT / 9:20 am ET

Based in Fort Worth, Texas, Sanara MedTech Inc., a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced the commercial launch of two new innovative products from Cook Biotech Inc.

Dr. Riam Shammaa, MD, is a pioneer scientist in the fields of cell therapy and biologics and holds several patents in the field.

Both Istradefylline and MB-204 are highly active derivatives of caffeine, the most widely consumed psychoactive drug in the world, whose consumption has been associated with a reduced risk for developing Parkinson’s disease, Alzheimer’s disease and improving concentration.

Lykan Bioscience, an innovative contract development and manufacturing organization (CDMO) focused on cell-based therapies, today announced plans to expand its state-of-the-art, purpose-built facility in Hopkinton, MA.

Keystone Bio acknowledges Cortexyme’s efforts in advancing Alzheimer’s disease research through its recently published Ph ll/lll GAIN Trial preliminary results.

In honor of Alzheimer’s Awareness Month, Cure Alzheimer’s Fund will host Dr. Erik Musiek for a live webinar on Tuesday, Nov. 30,

With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business Development effective November 1st , 2021.

IO Biotech, Inc. (Nasdaq: IOBT) (“IO Biotech”) today announced the closing of its initial public offering of 8,222,500 shares of its common stock, including the exercise in full by the underwriters’ option to purchase 1,072,500 additional shares of common stock,] at the initial public offering price of $14.00 per share.

The new capital will accelerate the development of Mekonos’ System on a Chip (SoC), expand commercial partnerships, and support talent acquisition